| |
| |
|
| Insider
Information: |
Stankovich Thomas |
| Relationship: |
Chief Financial Officer |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
90,265 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,622 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,265 |
|
|
| Total
Value |
$2,622 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-7.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -399.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Response Genetics Inc |
RGDX |
Vice President and CFO |
2009-12-14 |
67,488 |
2009-12-10 |
0 |
Premium* |
|
|
ReShape Lifesciences Inc |
RSLS |
Chief Financial Officer |
2024-05-31 |
22,777 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RSLS |
ReShape Lifesciences Inc |
Chief Financial OfficerOfficer |
• • – |
2021-06-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,613 |
|
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2021-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
372,744 |
406,357 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
364,756 |
697,517 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2024-02-29 |
4 |
S |
$0.17 |
$7 |
D/D |
(43) |
22,825 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-11-30 |
4 |
S |
$0.23 |
$9 |
D/D |
(39) |
22,910 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-12-31 |
4 |
S |
$0.25 |
$11 |
D/D |
(42) |
22,868 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2024-05-31 |
4 |
S |
$0.25 |
$12 |
D/D |
(48) |
22,777 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-10-25 |
4 |
S |
$0.27 |
$35 |
D/D |
(131) |
22,949 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-10-11 |
4 |
S |
$0.93 |
$36 |
D/D |
(39) |
23,080 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-08-24 |
4 |
S |
$1.42 |
$55 |
D/D |
(39) |
23,237 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-09-01 |
4 |
S |
$0.89 |
$105 |
D/D |
(118) |
23,119 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-08-04 |
4 |
S |
$1.43 |
$154 |
D/D |
(108) |
23,276 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-07-06 |
4 |
S |
$1.47 |
$156 |
D/D |
(106) |
23,384 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-04-30 |
4 |
S |
$2.36 |
$227 |
D/D |
(96) |
5,886 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-05-31 |
4 |
S |
$2.41 |
$236 |
D/D |
(98) |
5,788 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-03-31 |
4 |
S |
$2.60 |
$283 |
D/D |
(109) |
5,982 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-02-28 |
4 |
S |
$4.25 |
$438 |
D/D |
(103) |
6,091 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-12-01 |
4 |
S |
$0.15 |
$1,112 |
D/D |
(7,357) |
325,404 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-01-24 |
4 |
S |
$7.49 |
$1,183 |
D/D |
(158) |
6,351 |
0 |
- |
|
| RGDX |
Response Genetics Inc |
Vice President and CFO |
• – – |
2009-12-14 |
4 |
B |
$1.22 |
$1,235 |
D/D |
1,000 |
67,488 |
2.66 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-09-06 |
4 |
S |
$0.39 |
$1,883 |
D/D |
(4,828) |
346,963 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2023-02-02 |
4 |
S |
$13.29 |
$2,087 |
D/D |
(157) |
6,194 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
S |
$0.47 |
$2,222 |
D/D |
(4,728) |
351,791 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Financial Officer |
• – – |
2022-11-04 |
4 |
S |
$0.27 |
$2,287 |
D/D |
(8,393) |
332,761 |
0 |
% |
|
| RSLS |
ReShape Lifesciences Inc |
CFO |
• – – |
2022-10-04 |
4 |
S |
$0.28 |
$2,329 |
D/D |
(8,293) |
338,670 |
0 |
% |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
